Bausch Health Companies Inc (BHC) Stock Forecast & Price Target
Bausch Health Companies Inc · NYSE
$4.53+0.04 (+1.00%)
15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 3 firms covering Bausch Health Companies Inc, 0 rate it Buy or better, 3 sit at Hold, and 0 rate it Sell or worse, a hold consensus. Targets are tightly clustered, $7.00 to $9.00, so the covering firms are broadly aligned. The average target of $8.00 sits 77% above the current $4.53. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees revenue growth near 5% this year and 0% next, consensus EPS building from about $1.19 next quarter toward $4.11 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS3 ratings
Hold
Strong Buy00%
Buy00%
Hold3100%
Sell00%
Strong Sell00%
Based on 3 analysts giving stock ratings to Bausch Health Companies Inc.
As of Jul, 0 of 3 firms rate BHC a Buy (3 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
BHC EPS & revenue forecast
EPS · NEXT QUARTER
$1.19
Range $1.01 – $1.36 · 5 analysts · +2% YoY
Next period, 5 analysts expect Bausch Health Companies Inc to earn $1.19 a share (range $1.01 – $1.36), versus $1.16 a year earlier. Full-year consensus is $4.30, growing to $4.11 the year after.
REVENUE · NEXT QUARTER
$2.7B
Range $2.7B – $2.8B · 5 analysts · +2% YoY
Revenue is expected to reach $2.7B (range $2.7B – $2.8B), +2.0% year-over-year. Full-year consensus is $10.7B, rising to $10.7B next year.
Top analysts covering Bausch Health Companies Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on BHC.
#1
David Amsellem
Piper Sandler · Rank #95
Sell
$3.00-33.7% to target
Overall win rate
50%
+ Follow
#2
Jason Gerberry
B of A Securities · Rank #136
Sell
$5.00+10.5% to target
Overall win rate
46%
+ Follow
#3
DM
Douglas Miehm
RBC Capital
Hold
$9.00+98.9% to target
Coverage
—
+ Follow
#4
GS
Glen Santangelo
Barclays
Hold
$7.00+54.7% to target
Coverage
—
+ Follow
#5
MF
Michael Freeman
Raymond James
Hold
$8.00+76.8% to target
Coverage
—
+ Follow
BHC stock forecast FAQ
What is BHC's average 12-month price target?+
The 3 analysts with a live target average $8.00 for Bausch Health Companies Inc over the next 12 months, ranging from a $9.00 high to a $7.00 low.
Is BHC stock a Buy, Sell or Hold right now?+
The current consensus is Hold. Of the 3 analyst ratings, 0 are Buy or Strong Buy, 3 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for BHC?+
The Street-high target is $9.00 (RBC Capital), and the Street-low is $7.00 (Barclays). The average of all 3 active targets is $8.00.
How many Wall Street analysts cover BHC?+
3 analysts have an active rating on Bausch Health Companies Inc, and 3 firms carry a live 12-month price target.
Who is the most accurate analyst covering BHC?+
Among analysts who currently cover BHC, David Amsellem of Piper Sandler has the strongest overall Quantellect track record (Rank #95). Their current call is Sell with a $3.00 target.
What is Bausch Health Companies Inc's projected EPS for next quarter?+
The consensus estimate is $1.19 per share (range $1.01 – $1.36) across 5 analysts. Full-year EPS is projected at $4.30, rising to $4.11 the following year.
How much revenue is Bausch Health Companies Inc expected to report next quarter?+
Consensus revenue is $2.7B (range $2.7B – $2.8B). Full-year revenue is projected at $10.7B, growing to $10.7B next year.
Have analysts been upgrading or downgrading BHC lately?+
As of Jul, 0 of 3 firms rate BHC a Buy (3 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their BHC calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
